These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 5798365)
1. Hypocalcemic activity of serum in patients with medullary carcinoma of the thyroid. Stephens CL; Braunstein H Am J Clin Pathol; 1969 Aug; 52(2):170-2. PubMed ID: 5798365 [No Abstract] [Full Text] [Related]
2. [Medullary cancer of the thyroid and hyperthyrocalcitonin syndrome]. Milhaud G; Coutris G; Tubiana M Presse Med (1893); 1969 Dec; 77(56):2129-32. PubMed ID: 5374252 [No Abstract] [Full Text] [Related]
3. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. Goltzman D; Potts JT; Ridgway RC; Maloof F N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025 [No Abstract] [Full Text] [Related]
4. Calcitonin in human serum. Detection by tissue culture bioassay in medullary carcinoma of the thyroid and other disorders. Raisz LG; Au WY; Simmons H; Mandelstam P Arch Intern Med; 1972 Jun; 129(6):889-93. PubMed ID: 5033285 [No Abstract] [Full Text] [Related]
12. Human calcitonin. Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma. Tashjian AH; Wolfe HJ; Voelkel EF Am J Med; 1974 Jun; 56(6):840-9. PubMed ID: 4598527 [No Abstract] [Full Text] [Related]
13. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid. Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287 [No Abstract] [Full Text] [Related]
14. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid]. Gautvik KM Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540 [No Abstract] [Full Text] [Related]
15. Medullary carcinoma of the thyroid gland: use of biochemical parameters in detection and surgical management of the tumor. Baylin SB Surg Clin North Am; 1974 Apr; 54(2):309-23. PubMed ID: 4361605 [No Abstract] [Full Text] [Related]
16. Immunoassay for human calcitonin. II. Clinical studies. Deftos LJ; Bury AE; Habener JF; Singer FR; Potts JT Metabolism; 1971 Dec; 20(12):1129-37. PubMed ID: 5001933 [No Abstract] [Full Text] [Related]
17. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland. Linehan WM; Farrell RE; Cooper CW; Wells SA Surg Forum; 1977; 28():110-2. PubMed ID: 617389 [No Abstract] [Full Text] [Related]
18. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 1: Preoperative diagnosis of medullary thyroid carcinoma--physical and roentgenologic findings and determination of plasma calcitonin level (author's transl)]. Obara T Nihon Gan Chiryo Gakkai Shi; 1976 Dec; 11(4):745-57. PubMed ID: 1035237 [No Abstract] [Full Text] [Related]
19. Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid. Cohen SL; MacIntyre I; Grahame-Smith D; Walker JG Lancet; 1973 Nov; 2(7839):1172-3. PubMed ID: 4127549 [No Abstract] [Full Text] [Related]
20. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum. Samaan NA; Hill CS; Beceiro JR; Schultz PN J Lab Clin Med; 1973 May; 81(5):671-81. PubMed ID: 4735426 [No Abstract] [Full Text] [Related] [Next] [New Search]